Pfizer’s Strategy Looks Shakier After Sickle-Cell Disappointment
The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.
Pfizer withdraws sickle-cell disease treatment
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...
‘You Can’t Really Prepare A Person Until They’re In It’: What It’s Like Dating With Sickle Cell Disease
A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...
The Gazette2d
Why gene therapy for sickle cell is slow to catch on with patients
LOS ANGELES (Reuters) - Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with ...
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
A daily battle: Kamarie Crawford faces on-going fight with Sickle Cell
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
Revolutionary sickle cell treatment providing hope and equity in action
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...
West Virginia MetroNews7h
Morgantown-based start-up launches pediatric sickle cell treatment, hosts Kenyan leader
Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...